153 related articles for article (PubMed ID: 2510940)
1. Protective immunity induced by low-virulence Candida albicans: cytokine production in the development of the anti-infectious state.
Vecchiarelli A; Cenci E; Puliti M; Blasi E; Puccetti P; Cassone A; Bistoni F
Cell Immunol; 1989 Dec; 124(2):334-44. PubMed ID: 2510940
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation by Candida albicans: crucial role of organ colonization and chronic infection with an attenuated agerminative strain of C. albicans for establishment of anti-infectious protection.
Vecchiarelli A; Mazzolla R; Farinelli S; Cassone A; Bistoni F
J Gen Microbiol; 1988 Sep; 134(9):2583-92. PubMed ID: 3076189
[TBL] [Abstract][Full Text] [Related]
3. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.
Brieland J; Essig D; Jackson C; Frank D; Loebenberg D; Menzel F; Arnold B; DiDomenico B; Hare R
Infect Immun; 2001 Aug; 69(8):5046-55. PubMed ID: 11447185
[TBL] [Abstract][Full Text] [Related]
4. A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice.
Mencacci A; Torosantucci A; Spaccapelo R; Romani L; Bistoni F; Cassone A
Infect Immun; 1994 Dec; 62(12):5353-60. PubMed ID: 7960114
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor, macrophage colony-stimulating factor, and interleukin 1 production within sponge matrix allografts.
Ford HR; Hoffman RA; Wing EJ; Magee DM; McIntyre LA; Simmons RL
Transplantation; 1990 Sep; 50(3):460-6. PubMed ID: 1698320
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF.
Wang M; Friedman H; Djeu JY
J Immunol; 1989 Jul; 143(2):671-7. PubMed ID: 2661688
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of granulocyte/macrophage colony-stimulating factor (GM-CSF) in enhancing macrophage resistance to Legionella pneumophila vs Candida albicans.
Yamamoto Y; Klein TW; Tomioka M; Friedman H
Cell Immunol; 1997 Feb; 176(1):75-81. PubMed ID: 9070320
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 2 is dispensable for acquired host immune resistance to Candida albicans in a murine model of disseminated candidiasis.
Villamón E; Gozalbo D; Roig P; O'Connor JE; Ferrandiz ML; Fradelizi D; Gil ML
Microbes Infect; 2004 May; 6(6):542-8. PubMed ID: 15158187
[TBL] [Abstract][Full Text] [Related]
10. Impaired immune response to Candida albicans in aged mice.
Murciano C; Villamón E; Yáñez A; O'Connor JE; Gozalbo D; Gil ML
J Med Microbiol; 2006 Dec; 55(Pt 12):1649-1656. PubMed ID: 17108267
[TBL] [Abstract][Full Text] [Related]
11. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
Neta R; Oppenheim JJ; Douches SD
J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
[TBL] [Abstract][Full Text] [Related]
12. Suppression of human monocyte function against Candida albicans by autologous IL-2-induced lymphokine-activated killer cells.
Wei S; Serbousek D; McMillen S; Blanchard DK; Djeu JY
J Immunol; 1991 Jan; 146(1):337-42. PubMed ID: 1898605
[TBL] [Abstract][Full Text] [Related]
13. Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence.
Schaller M; Mailhammer R; Grassl G; Sander CA; Hube B; Korting HC
J Invest Dermatol; 2002 Apr; 118(4):652-7. PubMed ID: 11918712
[TBL] [Abstract][Full Text] [Related]
14. Production of cytokines by peripheral blood monocytes/macrophages infected with human immunodeficiency virus type 1 (HIV-1).
Molina JM; Schindler R; Ferriani R; Sakaguchi M; Vannier E; Dinarello CA; Groopman JE
J Infect Dis; 1990 May; 161(5):888-93. PubMed ID: 2182729
[TBL] [Abstract][Full Text] [Related]
15. Anti-proliferative effect of IFN-gamma in immune regulation. IV. Murine CTL clones produce IL-3 and GM-CSF, the activity of which is masked by the inhibitory action of secreted IFN-gamma.
Gajewski TF; Fitch FW
J Immunol; 1990 Jan; 144(2):548-56. PubMed ID: 2104898
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation by a low-virulence, agerminative variant of Candida albicans. Further evidence for macrophage activation as one of the effector mechanisms of nonspecific anti-infectious protection.
Bistoni F; Verducci G; Perito S; Vecchiarelli A; Puccetti P; Marconi P; Cassone A
J Med Vet Mycol; 1988; 26(5):285-99. PubMed ID: 2853217
[TBL] [Abstract][Full Text] [Related]
17. Candida albicans and Candida krusei differentially induce human blood mononuclear cell interleukin-12 and gamma interferon production.
Xiong J; Kang K; Liu L; Yoshida Y; Cooper KD; Ghannoum MA
Infect Immun; 2000 May; 68(5):2464-9. PubMed ID: 10768932
[TBL] [Abstract][Full Text] [Related]
18. Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity.
Hart PH; Whitty GA; Piccoli DS; Hamilton JA
J Immunol; 1988 Sep; 141(5):1516-21. PubMed ID: 3137258
[TBL] [Abstract][Full Text] [Related]
19. Selective production of interleukin 3 (IL3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in vitro by murine L3T4+ T cells: lack of spontaneous IL3 and GM-CSF production by Ly-2-/L3T4- lpr subset.
Davignon JL; Kimoto M; Kindler V; De Kossodo S; Vassalli P; Izui S
Eur J Immunol; 1988 Sep; 18(9):1367-72. PubMed ID: 3139430
[TBL] [Abstract][Full Text] [Related]
20. Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis.
Schaller M; Boeld U; Oberbauer S; Hamm G; Hube B; Korting HC
Microbiology (Reading); 2004 Sep; 150(Pt 9):2807-2813. PubMed ID: 15347740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
